Breaking News, Promotions & Moves

Onconova Appoints Corporate Development VP

Mr. Abraham “Avi” Oler will be primarily responsible for business development, investor relations, and legal affairs

Onconova Therapeutics announced that Mr. Abraham “Avi” Oler has joined Onconova’s management team as vice president, Corporate Development and General Counsel.  Mr. Oler will be primarily responsible for business development, investor relations, and legal affairs of the Company. To help further advance Rigosertib, the Company’s Phase 3 candidate for MDS, Mr. Oler’s focus will be on forging new collaborations in additional geographies.  Rigosertib is currently partnered with SymBio Pharmace...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters